TTYH3 as A Potential Drug Target for Various Diseases (G80727)

Target Name: TTYH3

NCBI ID: G80727

TTYH3

TTYH3 as A Potential Drug Target for Various Diseases

TTYH3 (TTYH3_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and kidneys. It is a member of the TYH3 gene family, which encodes a protein known as TYH3. This protein is known to play a role in the regulation of various cellular processes, including cell signaling, DNA replication, and inflammation.

Recent studies have identified TTYH3 as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because TTYH3 has been shown to interact with a variety of molecules, including transcription factors, DNA replicators, and signaling proteins.

One of the key reasons for the potential of TTYH3 as a drug target is its ability to modulate the activity of various cellular signaling pathways. For example, studies have shown that TTYH3 can inhibit the activity of the transcription factor NF-kappa-B, which is involved in a variety of cellular processes, including inflammation, stress response, and DNA replication. This suggests that TTYH3 may have therapeutic potential for diseases that are characterized by inflammation or other disruptions in cellular signaling pathways.

Another potential mechanism by which TTYH3 may be involved in the development of certain diseases is its role in the regulation of DNA replication. TTYH3 has been shown to interact with the DNA replication factor DFN1, which is involved in ensuring the accuracy and efficiency of DNA replication. This suggests that TTYH3 may be involved in the regulation of cell division, which is critical for the growth and development of tissues and organs.

In addition to its role in cell signaling and DNA replication, TTYH3 has also been shown to play a role in the regulation of inflammation. This is because TTYH3 is involved in the production of various signaling molecules that are involved in the immune response. For example, studies have shown that TTYH3 can modulate the activity of the immune protein interleukin-1 (IL-1), which is involved in the regulation of inflammation and immune responses.

Overall, TTYH3 is a protein that has the potential to be a drug target for the treatment of a variety of diseases. Its ability to modulate the activity of various cellular signaling pathways, as well as its role in the regulation of DNA replication and inflammation, make it an attractive target for further research and development.

Protein Name: Tweety Family Member 3

Functions: Probable large-conductance Ca(2+)-activated chloride channel. May play a role in Ca(2+) signal transduction

The "TTYH3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TTYH3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets